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Endocrine disruptors (EDs) have been studied
quite extensively in environmental biology
(Toppari et al. 1996); however, their exact
effects on humans are uncertain. Rising rates
of hormone-dependent cancers, such as breast,
ovary, and testicular cancer, appear to be
linked to rising levels of EDs contaminating
the environment (Weir et al. 2000), although
a causal link between observed abnormalities
and chemical exposure has not been estab-
lished (Baker 2001). These compounds may
modulate both the endocrine, neuronal, and
immune systems resulting in alteration of
homeostasis, reproduction, development, and
behavior(Amaral Mendes 2002).
EDs are not classical poisons or carcino-
gens (Colborn et al. 1996); the detailed mech-
anisms by which EDs exert their effects are
gradually being elucidated (Tapiero et al.
2002). They can directly initiate or inhibit
actions mediated by members of the super-
family of zinc ﬁnger nuclear receptors, such as
estrogen, androgen, and triiodothyronine
receptors, although their chemical structures
may not resemble those of steroids or related
hormones. Alternatively, they may exert indi-
rect genomic effects by modulating the metab-
olism of hormones. In this context, sulfation
plays a key role because the cellular availability
of steroid and thyroid hormones is modulated
by their sulfation and desulfation by sulfo-
transferases and sulfatases, respectively.
Sulfation of hydroxyl residues in these hor-
mones renders them inactive and speeds exit
from the cell, whereas desulfation regenerates
their endocrine potential. A decrease in the
sulfation/desulfation ratio could therefore lead
to inappropriately high levels of hormones
within cells (Falany et al. 2002; Kirk et al.
2001; Qian et al. 1998).
Dehydroepiandrosterone (DHEA) and its
sulfate-ester (DHEAS) are neurosteroids
secreted mainly by the adrenal cortex and
gonads, although synthesis of DHEAS can
also take place in the central nervous system
(CNS). In humans, plasma concentrations of
DHEAS peak during the teenage years and
thereafter decline by about 10% per decade
(Ravaglia et al. 1996). It has been shown that
any disruption of sulfation of DHEA or preg-
nenolone can block memory processes in
rodents (Vallée et al. 2001), probably because
these neurosteroids modulate acetylcholine
release and γ-aminobutyric acid (GABA) and
N-methyl-D-aspartate (NMDA) receptor
action in the cortex and hippocampus
(Dubrovsky 2005; Mayo et al. 2003). Results
from studies in humans have been rather less
conclusive because in vivo experiments are
not possible. The situation is confounded
because the brain can synthesize DHEA inde-
pendently of the adrenal gland; therefore,
measurement of DHEA and DHEAS in the
plasma may not give a true indication of lev-
els in the CNS (Racchi et al. 2003). Reduced
levels of both plasma DHEAS and preg-
nenolone sulfate have been linked with
decreased cognitive function (Armanini et al.
2003; Mayo et al. 2003). However, there is
evidence that DHEA levels may exert subtle
effects, particularly in Alzheimer’s disease
(Vallée et al. 2001). DHEA sulfation is cat-
alyzed by SULT 2A1, a member of the
SULT 2 subfamily of the sulfotransferases,
which mainly acts on endogenous hydroxy-
steroids, including pregnenolone, but can also
sulfate various xenoestrogens and drugs. SULT
2A1 is unusual in that, although it has a Km for
DHEA of about 2 µM (Chang et al. 2001),
the physiologic concentration of DHEA ranges
from 1–20 nM (Heuser et al. 1998). 
The essential co-factor in sulfation reactions
is PAPS, which is synthesized in vivo by oxida-
tion of sulfur-containing amino acids (Do and
Tappaz 1996; Griffith 1987). Four enzymes
play a key role in the synthesis of PAPS from
cysteine. These are cysteine dioxygenase type I
(CDO1), sulfite oxidase (SUOX), and the
bifunctional enzymes 3´-phosphoadenosine
5´-phosphosulfate synthase 1 and 2 (PAPSS1
and PAPSS2). In humans, the supply of PAPS
appears to be rate limiting for sulfation of both
endogenous and exogenous compounds.
Chemicals produced from the plastics and
detergent industries, such as alkylphenols and
bisphenol A, have been discovered to be estro-
genic (Jobling et al. 1995). Plasticizers are
ubiquitous in the environment at low levels
and may be present in mixtures that result in
additive, antagonistic, and/or synergistic effects
(Guenther et al. 2002). In this article we show
that a range of plasticizers commonly encoun-
tered in the environment act as competitive
inhibitors of SULT 2A1 when sulfating
physiologic concentrations of DHEA. In addi-
tion, they reduce steady-state mRNA levels of
enzymes involved in PAPS synthesis.
This article is part of the monograph “Endocrine
Disruptors—Exposure Assessment, Novel End
Points, and Low-Dose and Mixture Effects.”
Address correspondence to R. Harris, School of
Biosciences, The University of Birmingham,
Edgbaston, Birmingham, B15 2TT, UK. Telephone:
44 (0)121 414 3393. Fax: 44 (0)121 414 5925.
E-mail: R.M.Harris@bham.ac.uk
We thank members of the Queen Elizabeth
Hospital Clinical Transplant Unit and The Liver
Research Laboratories for assistance with collection
of liver tissue.
This study was supported by the European
Commission’s Quality of Life Programme, Key
Action Environment and Health, contract QLK4-
CT-2002-02637.
The authors declare they have no competing
ﬁnancial interests.
Received 22 May 2006; accepted 23 October 2006.
Effects of Endocrine Disruptors on Dehydroepiandrosterone
Sulfotransferase and Enzymes Involved in PAPS Synthesis: 
Genomic and Nongenomic Pathways
Robert Harris,1 Nahid Turan,2 Christopher Kirk,1 David Ramsden,2 and Rosemary Waring1
1School of Biosciences, The University of Birmingham, Edgbaston, Birmingham, United Kingdom; 2Department of Medicine, Division of
Medical Sciences, The University of Birmingham, Queen Elizabeth Hospital, Birmingham, United Kingdom
BACKGROUND: Sulfation plays an important role both in detoxiﬁcation and in the control of steroid
activity. Studies in rodents have shown that the conversion of dehydroepiandrosterone (DHEA) to
DHEA-sulfate is involved in learning and the memory process.
METHODS: The effects of a range of plasticizers and related compounds commonly encountered in
the environment were evaluated kinetically against human DHEA sulfotransferase (SULT 2A1) and
by reverse transcriptase-polymerase chain reaction (RT-PCR) against several enzymes involved in
the synthesis of the sulfotransferase cofactor adenosine 3´-phosphate 5´-phosphosulfate (PAPS).
RESULTS: We found that several of the chemicals acted as competitive inhibitors of SULT 2A1 (Ki
for 4-tert-octylphenol is 2.8 µM). Additionally, after treatment of TE 671 cells with 0.005–0.5 µM
4-n-octylphenol, bis(2-ethylhexyl)phthalate, and diisodecyl phthalate, real-time RT-PCR showed
dose-dependent decreases in the steady-state mRNA levels of cysteine dioxygenase type I, sulﬁte
oxidase, and 3´-phosphate 5´-phosphosulfate synthase I.
CONCLUSIONS: These data suggest that environmental contaminants may exert effects on neuronal
function both by direct inhibition of sulfotransferase enzymes and by interrupting the supply of
PAPS, which has wider implications for endocrine disruption and xenobiotic metabolism.
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Materials. We used the following EDs in this
study: bis(2-ethylhexyl)adipate, bis(2-ethyl-
hexyl)phthalate, 4-n-nonylphenol, and
2,4-dichlorophenol from Lancaster Synthesis
(Morecambe, UK); resorcinol from Riedel-de
Haën Fine Chemicals (Seelze, Germany);
dioctyl phthalate and diisodecyl phthalate from
Fluka (CH-9471 Buchs SG, Switzerland); ben-
zyl butyl phthalate, bisphenol A, bisphenol A
dimethacrylate, 4-chloro-3-methylphenol,
diisononyl phthalate, 4-n-octylphenol, 4-tert-
octylphenol, and 2-phenylphenol from Aldrich
(Gillingham, UK); and dibutyl phthalate,
17β-estradiol (E2), and diethylstilbestrol (DES)
from Sigma (Poole, UK).
All cell culture reagents were purchased
from PAA Laboratories Ltd. (Yeovil, UK).
TE 671 cells were obtained from the
European Collection of Cell Cultures (Porton
Down, UK). RNA-Bee was from AMS
Biotechnology (Europe) Ltd. (Abingdon,
UK). We purchased RNAsecure Reagent
from Ambion (Huntingdon, UK), primers
from Alta Bioscience (Birmingham, UK), and
SYBR Green PCR Master Mix from Applied
Biosystems (Cheshire, UK). Agarose and all
other RT-PCR reagents were purchased from
Bioline (London, UK), and all other chemi-
cals and reagents were from Sigma.
SULT 2A1 activity. We screened 16 puta-
tive endocrine-disrupting chemicals for activity
against the sulfation of 10 nM DHEA at a satu-
rating concentration or 100 µM, whichever was
greater. Human liver cytosol was used as a
source of SULT 2A1. Liver tissue was obtained
either from fully informed consenting patients
undergoing transplantation for end-stage liver
disease or from normal donor liver, surplus to
surgical requirements. Ethical approval for the
use of these tissues for research purposes was
granted by South Birmingham Health
Authority Local Research Ethics Committee
(Reference CA/5192). The sulfation of physio-
logically relevant concentrations of DHEA was
assayed using tritiated DHEA in a buffer of
sodium phosphate (20 mM), magnesium
acetate (5 mM), and disodium edetate
(0.1 mM) at pH 7.0 by a method developed
for determining E2 sulfation, as previously
described (Harris et al. 2004). The uninhibited
cytosol metabolized < 10% of the DHEA, and
the sulfation of DHEA concentrations as low
as 0.25 nM could reliably be measured.
Cell culture. Human medulloblastoma-
derived TE 671 cells were routinely cultured in
Dulbecco’s modiﬁed Eagle medium (DMEM)
with 10% (vol/vol) heat-inactivated fetal calf
serum, 2.5 µg/mL amphotericin B, penicillin
(100 U/mL)/streptomycin (100 µg/mL) and
2 mM L-glutamine. Cells were incubated at
37°C in 5% carbon dioxide.
For dosing experiments, cells were grown
in phenol red–free DMEM, supplemented as
before, for 72 hr prior to splitting, counting,
and plating the cells in dosing media [phenol
red–free DMEM supplemented as before,
except with 10% (vol/vol) heat-inactivated
dialyzed fetal calf serum]. Cells were counted
using a Fuchs-Rosenthal Hemocytometer
(Fisher Scientific, Loughborough, UK) and
trypan blue (0.4% wt/vol). 
TE 671 cells were plated at 4 × 104
cells/well in 24-well cell culture plates for gene
expression experiments. The plates were incu-
bated for 24 hr to equilibrate prior to dosing
with 0.005–0.5 µM of the EDs. E2 and DES
(0.1–10 nM) were used as positive controls.
Dimethyl sulfoxide (DMSO) was used as the
solvent carrier.
RT-PCR primers. The gene sequences of
interest were obtained from GenBank (2006).
We used Oligo (MedProbe, Oslo, Norway) to
design oligonucleotide primers for CDO1
(GenBank accession no. NM_001801), SUOX
(GenBank accession no. BC065193), PAPSS1
(GenBank accession no. Y10387), and HPRT1
(GenBank accession no. M26434) (Table 1).
Primer pairs were designed to cross exon–
intron boundaries to minimize genomic DNA
amplification. We selected hypoxanthine
phosphoribosyltransferase 1 (HPRT1) for the
internal standard because its expression was
relatively low compared with other standards
and it is thought to be unaffected by estrogens
(Pernas-Alonso et al. 1999). 
RNA isolation. Total RNA was extracted
using RNA-Bee, following the manufacturer’s
guidelines; RNA was extracted from TE
671 cells dosed for 24 hr with 0.005–0.5 µM
EDs, 0.1–10 nM, E2 or DES (in quadruplicate
for each dose). RNA pellets were resuspended
in 25 µL of 1× RNAsecure Reagent and sam-
ples were heated at 60°C for 10 min. Aliquots
were taken for agarose gel electrophoresis,
RNA spectrophotometric quantiﬁcation, and
the reverse transcription (RT) reaction. 
RNA quantiﬁcation. RNA was quantiﬁed
using the GeneQuant II RNA/DNA calculator
(Pharmacia Biotech, Amersham Biosciences
UK Ltd., Buckinghamshire, UK) with a capil-
lary cell and quartz capillary tubes. The purity
of RNA was determined from the A260/280
ratio and the concentration determined from
the absorption at 260 nm. 
Real time RT-PCR. RT products were pro-
duced by heating 10 µL (1 µg) RNA and 2 µL
(0.5 µg) ﬁrst strand (poly T) primers for 5 min
at 70°C. dNTP mix (4 µL of 10 mM, 2.5 mM
of each base), 4 µL reaction buffer (5×), and
0.5 µL BIOSCRIPT (MMLV-reverse tran-
scriptase RNase H minus) (200 U/µL) were
added and samples incubated for 60 min at
42°C. Reactions were stopped by heating for
10 min at 70°C.
Real-time PCR was performed using the
ABI PRISM 7000 Sequence Detection
System (Applied Biosystems). Reaction mix-
tures (per well) contained: 0.4 µL (10 µM)
forward primer; 0.4 µL (10 µM) reverse
primer; 10 µL SYBR Green PCR Master Mix;
8.2 µL nuclease-free water, and 1 µL RT
product. No-template controls were also pre-
pared. The annealing temperature selected
was 60°C, and the program was run for
44 cycles. A dissociation protocol was also
run, and the melting curve distinguished any
nonspeciﬁc product and primer-dimers.
The expression of CDO1, SUOX, and
PAPSS1 mRNA was investigated in TE 671
cells treated for 24 hr with EDs as above. The
expression of the internal standard HPRT was
also assayed for each sample. Relative gene
expression levels were obtained using the
∆∆Ct method (Winer et al. 1999). All sam-
ples were run in quadruplicate.
Statistical analysis. The results are pre-
sented as means ± SE. Statistical signiﬁcance
of the differences between the undosed con-
trol groups and test groups were assessed by
Harris et al.
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Table 2. Ki values for the inhibition of DHEA sulfa-
tion by putative endocrine-disrupting chemicals.
Compound Ki (µM)
4-n-Nonylphenol 10.5 ± 0.6
4-n-Octylphenol 13.7 ± 0.2
4-tert-Octylphenol 2.8 ± 0.1
Bisphenol A 16.3 ± 0.8
Benzyl butyl phthalate 7.0 ± 0.8
Dibutyl phthalate 21.5 ± 1.4
Values are mean ± SE; n = 4. Only results for those com-
pounds causing > 50% inhibition of enzyme activity at
100 µM are shown. 
Table 1. Primers for real-time RT-PCR.
No. of  Oligo annealing 
Primer Sequence (5´→3´) base pairs cDNA size (bp) temperature (°C)
HPRT1
Forward CCTGCTGGATTACATTAAAGCACTG 25 282 56.1
Reverse CTTCGTGGGGTCCTTTTCACCAGC 24 63.5
CDO1
Forward GGGTGAAGGACATGGCAGCAG 21 360 59
Reverse AGCGAGCCCGAAGTTGCATTT 21 59.7
SUOX
Forward AGCACCCATCCCTCCTACCCC 21 494 59.2
Reverse TCCTGAGCAGCCCTACACCGA 21 59.2
PAPSS1
Forward GATGTATGAGGGCCGCCGTGT 21 667 60.5
Reverse AGGGGCCATCGTCAGCACTTT 21 59.4Effects of endocrine disruptors on DHEA sulfation
Environmental Health Perspectives • VOLUME 115 | SUPPLEMENT 1 | December 2007 53
one-way analysis of variance (ANOVA) fol-
lowed by Dunnet multiple comparisons test,
using GraphPad Instat Software (GraphPad
Software, Inc., San Diego, CA, USA).
ANOVA was also used to test linear trends
between column means and column num-
bers. All values with p<0.05 were considered
statistically signiﬁcant.
Results
SULT 2A1 activity. Of the plasticizers tested,
only six caused > 50% inhibition of SULT 2A1
enzyme activity at a concentration of 100 µM;
crude IC50 (concentration inhibited by 50%)
values for these compounds were obtained from
a second set of assays. Using these data, we per-
formed duplicate experiments in which the sul-
fation of DHEA, at concentrations of 2.5, 5,
10, and 20 nM, was measured with the test
compounds at nine concentrations ranging
from 0 to approximately twice the IC50 to
determine the nature of the inhibition. We
evaluated the results graphically by standard
kinetic procedures(Cornish-Bowden 2004). All
six compounds were competitive inhibitors,
with no evidence of interaction at any allosteric
site. The values for the inhibition constants (Ki)
are shown in Table 2.
Enzymes of PAPS synthesis. The real-time
RT-PCR results were expressed as relative
gene expression levels compared with
undosed controls using the ∆∆Ct method.
Treatment with 0.005–0.5 µM 4-n-octyl-
phenol (Figure 1) showed significant dose-
dependent decreases in SUOX (p<0.02) and
PAPSS1 (p<0.001) steady-state mRNA lev-
els. CDO1 mRNA expression also showed a
dose-dependent decreasing trend. Cells
treated with 4-n-nonylphenol showed a very
significant dose-dependent decrease in
PAPSS1 mRNA levels (p<   0.01). 
Bisphenol A dimethacrylate treatment did
not affect CDO1, however, SUOX and
PAPSS1 (p<0.0001) mRNA expression levels
both decreased in a dose-dependent manner.
Diisodecyl phthalate treatment (Figure 2)
showed extremely signiﬁcant dose-dependent
decreases in CDO1 (p<0.01) and SUOX
(p<0.001) mRNA levels, and a clear decreas-
ing trend was also observed for PAPSS1.
Treatment with bis(2-ethylhexyl)phthalate
(Figure 3) showed dose-dependent decreases in
CDO1, SUOX and PAPSS1 (p<0.004) expres-
sion levels. Treatment with 2,4-dichlorophenol
and 4-chloro-3-methylphenol did not show sig-
nificant decreases in CDO1, SUOX and
PAPSS1 mRNA levels.
Treatment with the other compounds had
no effect on CDO1, SUOX and PAPSS1
mRNA expression levels. 
Discussion
Chemicals used as plasticizers are released into
the environment in large quantities. They are
hydrophobic and are able to both bioaccumu-
late (Van der Oost et al. 2003) and cross the
blood–brain barrier (Waterhouse 2003). The
results from the present study clearly show
that some plasticizers can inhibit SULT 2A1
at micromolar concentrations. Concentrations
of the alkylphenols in polluted waters can
reach 10–70 nM, and these lipophilic com-
pounds have been found to bioaccumulate
400-fold in estuarine fish (see Kirk et al.
2003). Nevertheless, even in the case of 4-tert-
octylphenol—the most potent of the
inhibitors in this study and one of the most
commonly used plasticizing agents—it is
unlikely that it reaches micromolar concentra-
tions in the human CNS. However, because
the physiologic concentration of DHEA is
very much lower than the Km of the enzyme
for this substrate, the Michaelis-Menten equa-
tion (v = VS/[Km + S], where v is the rate of
reaction, V is the maximum rate of reaction, S
is the substrate concentration, and Km is the
Michaelis constant) simplifies to v = VS/Km.
In the presence of a competitive inhibitor, the
rate is given by v = VS/Km(1 + i/Ki), where i is
the inhibitor concentration. Hence, even rela-
tively low concentrations of inhibitor will
interfere with DHEA sulfation. Long-term
accumulation of plasticizers in brain tissue
may therefore reduce the efﬁciency of memory
processes as pregnenolone sulfate and DHEAS
are required for acetyl choline release and
receptor modulation.
From these results, it appears that the pres-
ence of a single benzyl or phenyl group and
another compact hydrophobic side-chain are
both important for tight binding to the active
site. Benzyl butyl phthalate is three times more
potent than the aliphatic dibutyl phthalate,
which is many times more potent than its
longer-chained counterparts. Similarly, 4-tert-
octylphenol, which has a compact, hydropho-
bic side-chain, binds nearly five times more
tightly than its straight-chain isomer. However,
although a single aromatic group appears to aid
binding, bisphenol A, which has two such
moieties, is a less potent inhibitor.
The real-time RT-PCR results also showed
significant dose-dependent decreases in
CDO1, SUOX, and PAPSS1 mRNA expres-
sion levels in TE 671 cells treated for 24 hr
with 0.005–0.5 µM 4-n-octylphenol, diisodecyl
phthalate, or bis(2-ethylhexyl)phthalate.
Endocrine-disrupting effects of some plasti-
cizers may therefore also be a consequence of
modulation of expression of enzymes supplying
PAPS for hormone sulfation. Our results indi-
cate that exposure to 4-n-octylphenol, diiso-
decyl phthalate, or bis(2-ethylhexyl)phthalate
may negatively affect the sulfate supply path-
way. This could result in reducing PAPS pro-
duction, giving increased levels of free
hormones and decreased capacity for detoxiﬁca-
tion via sulfate conjugation
Although in vitro studies with tissue
homogenates and human cell lines cannot
necessarily be correlated with the experiences
in vivo, it is increasingly evident from recent
work (Chen et al. 2006) that DHEAS plays
an important role in memory function. In
addition. animal experiments have shown that
chemicals of the type used in the present
study inhibit cognitive function (MacLusky
et al. 2005), alter synaptic plasticity (Kawato
2004), and affect the acquisition of memory
(Carr et al. 2003). Similarly, exposure to poly-
chlorinated biphenyls and brominated fire
4-n-Octylphenol concentration (µM)
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Figure 1. Real-time RT-PCR results for TE 671 cells
treated for 24 hr with 4-n-octylphenol. Data are
means ± SEs (n = 4). 
*Significantly different from 0 µM control at p < 0.05.
**Very signiﬁcant at p < 0.01 (ANOVA with Dunnet multiple
comparisons test).
Diisodecyl phthalate concentration (µM)
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Figure 2. Real-time RT-PCR results for TE 671 cells
treated for 24 hr with diisodecyl phthalate. Data are
means ± SEs (n = 4). 
*Significantly different from 0 µM control at p < 0.05.
**Very signiﬁcant at p < 0.01 (ANOVA with Dunnet multiple
comparisons test).
bis(2-Ethylhexyl)phthalate concentration (µM)
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Figure 3. Real-time RT-PCR results for TE 671 cells
treated for 24 hr with bis(2-ethylhexyl)phthalate.
Data are means ± SEs (n = 4).
*Significantly different from 0 µM control at p < 0.05.
**Very signiﬁcant at p < 0.01 (ANOVA with Dunnet multiple
comparisons test).Harris et al.
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retardants has also been linked to adverse
effects on both memory and learning (Fonnum
et al. 2006). Although the genetic mechanisms
were not explored in detail, the authors of this
article have analyzed the ﬁrst 4,000 bases of the
upstream ﬂanking region of the PAPSS1 gene
using the MatInspector program (Genomatix
Software GmbH, Munich, Germany). This
revealed two potential estrogen response ele-
ments 483–501 and 2916–2934 bases
upstream of the transcription start site, and
two aryl hydrocarbon receptor response ele-
ments 39–61 and 346–368 bases upstream of
the transcription start site. In addition, there
were other potential nuclear hormone receptor
response elements and numerous cAMP
response elements. Endocrine disruptors,
including these plasticizers, often have weak
estrogenic properties, interact with the aryl
hydrocarbon receptor (Bonefeld-Jørgensen
et al. 2007), and inﬂuence a range of cell sig-
naling pathways. The reduction in PAPSS1
expression could occur via any of these routes.
In conclusion, the results from these
experiments suggest that plasticizers may have
deleterious effects on physiologic function
including neuronal pathways and that, where
possible, alternatives should be sought that do
not interact with critical metabolic pathways.
The information provided by the present
study creates novel avenues for hazard identi-
fication and risk assessments and has shown
that environmental contaminants may inter-
act with nonreproductive steroidal function.
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